Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289)
HKEX:2289
Holding HK:2289?
Track your performance easily
2289 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$6.81 - HK$14.82
Previous CloseHK$9
Volume0.00
Average Volume (3M)246.32K
Market Cap
HK$972.00M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)17.4
Beta0.60
Next Earnings
Mar 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 22, 2024Dividend Yield3.66%
Share Statistics
EPS (TTM)0.52
Shares OutstandingN/A
10 Day Avg. Volume700
30 Day Avg. Volume246,318
Standard Deviation0.15
R-Squared0.00017
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Charmacy Pharmaceutical Co., Ltd. Class H News
PremiumCompany Announcements
Charmacy Pharmaceutical Plans Key Shareholder Meeting on New Agreements
PremiumCompany Announcements
Charmacy Pharmaceutical Delays Circular Publication Amid Framework Agreements
PremiumCompany Announcements
Charmacy Pharmaceutical Signs New Agreements with Jiangyao
PremiumCompany Announcements
Charmacy’s Steady Growth in Mid-Year Financials
PremiumCompany Announcements
Charmacy Pharmaceutical Schedules Key Board Meeting
PremiumCompany Announcements
Charmacy Elects Zheng Xiyue as SupervisorPremiumCompany Announcements
Charmacy Announces Final 2023 Dividend Payout
PremiumCompany Announcements
Charmacy Pharmaceutical Announces AGM Outcomes2289 FAQ
What was Charmacy Pharmaceutical Co., Ltd. Class H’s price range in the past 12 months?
Charmacy Pharmaceutical Co., Ltd. Class H lowest stock price was HK$6.81 and its highest was HK$14.82 in the past 12 months.
What is Charmacy Pharmaceutical Co., Ltd. Class H’s market cap?
Currently, no data Available
When is Charmacy Pharmaceutical Co., Ltd. Class H’s upcoming earnings report date?
Charmacy Pharmaceutical Co., Ltd. Class H’s upcoming earnings report date is Mar 27, 2025 which is in 94 days.
How were Charmacy Pharmaceutical Co., Ltd. Class H’s earnings last quarter?
Charmacy Pharmaceutical Co., Ltd. Class H released its earnings results on Aug 28, 2024. The company reported HK$0.268 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.268.
Is Charmacy Pharmaceutical Co., Ltd. Class H overvalued?
According to Wall Street analysts Charmacy Pharmaceutical Co., Ltd. Class H’s price is currently Overvalued.
Does Charmacy Pharmaceutical Co., Ltd. Class H pay dividends?
Charmacy Pharmaceutical Co., Ltd. Class H pays a Annually dividend of HK$0.324 which represents an annual dividend yield of 3.66%. See more information on Charmacy Pharmaceutical Co., Ltd. Class H dividends here
What is Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate?
Charmacy Pharmaceutical Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Charmacy Pharmaceutical Co., Ltd. Class H have?
Charmacy Pharmaceutical Co., Ltd. Class H has 108,000,000 shares outstanding.
What happened to Charmacy Pharmaceutical Co., Ltd. Class H’s price movement after its last earnings report?
Charmacy Pharmaceutical Co., Ltd. Class H reported an EPS of HK$0.268 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.744%.
Which hedge fund is a major shareholder of Charmacy Pharmaceutical Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2289
---
Charmacy Pharmaceutical Co., Ltd. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-28.87%
12-Months-Change
Fundamentals
Return on Equity
8.93%
Trailing 12-Months
Asset Growth
14.98%
Trailing 12-Months
Technical Analysis
---